Literature DB >> 25389047

A novel imprinted transgene located near a repetitive element that exhibits allelic imbalance in DNA methylation during early development.

Koji Uchiyama1, Daisuke Watanabe, Michiko Hayasaka, Kazunori Hanaoka.   

Abstract

A mouse line carrying a lacZ transgene driven by the human EEF1A1/EF1 alpha promoter was established. Although the promoter is known to show ubiquitous activity, only paternal transgene alleles were expressed, resulting in a transgene imprinting. At mid-gestation, the promoter sequence was differentially methylated, hypomethylated for paternal and hypermethylated for maternal alleles. In germline, the promoter was a typical differentially methylated region. After fertilization, however, both alleles were hypermethylated. Thus, the differential methylation of the promoter required for transgene imprinting was re-established during later embryonic development independently of the germline differential methylation. Furthermore, also a retroelement promoter closely-flanking imprinted transgene and its wild type counterpart displayed similar differential methylation during early development. The retroelement promoter was methylated differentially also in germline, but in an opposite pattern to the embryonic differential methylation. These results suggest that there might be an unknown epigenetic regulation inducing transgene imprinting independently of DNA methylation in the transgene insertion site. Then, besides CpG dinucleotides, non-CpG cytosines of the retroelement promoter were highly methylated especially in the transgene-active mid-gestational embryos, suggesting that an unusual epigenetic regulation might protect the active transgene against de novo methylation occurring generally in mid-gestational embryo.
© 2014 The Authors Development, Growth & Differentiation © 2014 Japanese Society of Developmental Biologists.

Entities:  

Keywords:  CpG islands; DNA methylation; genomic imprinting; retroelements; transgenic mice

Mesh:

Substances:

Year:  2014        PMID: 25389047     DOI: 10.1111/dgd.12182

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  4 in total

Review 1.  While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.

Authors:  Yan He; Chengfu Yuan; Lichan Chen; Yanjie Liu; Haiyan Zhou; Ningzhi Xu; Dezhong Joshua Liao
Journal:  Int J Med Sci       Date:  2018-01-19       Impact factor: 3.738

Review 2.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

3.  Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modifications.

Authors:  Miriam Pacetti; Laura De Conti; Luciano E Marasco; Maurizio Romano; Mohammad M Rashid; Martina Nubiè; Francisco E Baralle; Marco Baralle
Journal:  Dis Model Mech       Date:  2022-04-29       Impact factor: 5.732

4.  The human EF1a promoter does not provide expression of the transgene in mice.

Authors:  Nariman Battulin; Alexey Korablev; Anastasia Ryzhkova; Alexander Smirnov; Evelyn Kabirova; Anna Khabarova; Timofey Lagunov; Irina Serova; Oleg Serov
Journal:  Transgenic Res       Date:  2022-08-12       Impact factor: 3.145

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.